Inventor · disambiguated record
Philipp Ermert
Also filed as: ERMERT PHILIPP
8 granted patents·1 pending application·37 citations·filing 2008–2016
82Inventor score
Technology areasA61P
Files withJANSSEN PHARMACEUTICA NV3OBRECHT DANIEL2STORCK PIERRE HENRI2BONGARTZ JEAN-PIERRE ANDRÉ MARC1POLYPHOR AG1
Top patents by PatentIndex Score
9 records- 0189US8288377B2Inhibitors of the interaction between MDM2 and p53STORCK PIERRE-HENRI·Filed 2008·Granted Oct 16, 2012·23 cites·15 claims
- 0275US9688696B2Piperidine/piperazine derivativesJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 27, 2017·1 cites·11 claims
- 0375US9512139B2Conformationally constrained, fully synthetic macrocyclic compoundsOBRECHT DANIEL·Filed 2010·Granted Dec 6, 2016·5 cites·11 claims
- 0474US10017481B2Conformationally constrained, fully synthetic macrocyclic compoundsPOLYPHOR AG·Filed 2013·Granted Jul 10, 2018·5 cites·15 claims
- 0573US9695191B2Conformationally constrained, fully synthetic macrocyclic compoundsOBRECHT DANIEL·Filed 2009·Granted Jul 4, 2017·3 cites·13 claims
- 0661US9120821B2Piperidine/piperazine derivativesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Sep 1, 2015·0 cites·10 claims
- 0760US8835437B2Piperidine/piperazine derivativesBONGARTZ JEAN-PIERRE ANDRÉ MARC·Filed 2008·Granted Sep 16, 2014·0 cites·14 claims
- 0852US9499567B2Piperidine/piperazine derivativesJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Nov 22, 2016·0 cites·9 claims
- 0945US2013005769A1Inhibitors of the interaction between mdm2 and p53STORCK PIERRE HENRI·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philipp Ermert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →